Literature DB >> 28652434

Elevated IL-4 and IFN-γ Levels in Muscle Tissue of Patients with Dermatomyositis.

Murat Giriş1, Hacer Durmuş2, Berrak Yetimler1, Hatice Taşli2, Yeşim Parman2, Erdem Tüzün3.   

Abstract

BACKGROUND/AIM: To investigate the contribution of muscle tissue-derived cytokines in dermatomyositis (DM).
MATERIALS AND METHODS: Muscle homogenates were prepared from deltoid muscle biopsy specimens of 10 patients with DM and eight controls with no pathological signs of myopathy. Interleukin (IL)-4, interferon (IFN)-γ and IL-17 levels were evaluated by enzyme-linked immunosorbent assay (ELISA) and immunoblotting analysis. Muscle strength grades were recorded.
RESULTS: Patients with DM showed significantly elevated muscle tissue IL-4 and IFN-γ levels, whereas IL-17 levels were comparable between patients with DM and controls. Immunoblotting studies confirmed ELISA results. In DM muscle specimens, IL-4 and IFN-γ levels were positively correlated, while no correlation was observed between IL-17 and the other two cytokines. Moreover, IL-4 and IFN-γ levels were significantly negative correlated with muscle strength grades for the deltoid muscle.
CONCLUSION: Our results confirm the involvement of T helper (Th) 1-type and Th2-type immunity in DM pathogenesis. Muscle tissue appears to contribute to muscle weakness in DM by producing inflammatory cytokines. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Dermatomyositis; ELISA; inerleukin-17; interferon-gamma; interleukin-4

Mesh:

Substances:

Year:  2017        PMID: 28652434      PMCID: PMC5566917          DOI: 10.21873/invivo.11108

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  14 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

Review 2.  The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies.

Authors:  Ilaria Cavazzana; Micaela Fredi; Carlo Selmi; Angela Tincani; Franco Franceschini
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

3.  MiR-146a Regulates Inflammatory Infiltration by Macrophages in Polymyositis/Dermatomyositis by Targeting TRAF6 and Affecting IL-17/ICAM-1 Pathway.

Authors:  Yuanqin Yin; Fei Li; Jing Shi; Songlin Li; Jingjing Cai; Youhong Jiang
Journal:  Cell Physiol Biochem       Date:  2016-11-25

4.  Preferential infiltration of interleukin-4-producing CXCR4+ T cells in the lesional muscle but not skin of patients with dermatomyositis.

Authors:  T Fujiyama; T Ito; N Ogawa; T Suda; Y Tokura; H Hashizume
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

5.  IL-4 abrogates T(H)17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells.

Authors:  Emmanuella Guenova; Yuliya Skabytska; Wolfram Hoetzenecker; Günther Weindl; Karin Sauer; Manuela Tham; Kyu-Won Kim; Ji-Hyeon Park; Ji Hae Seo; Desislava Ignatova; Antonio Cozzio; Mitchell P Levesque; Thomas Volz; Martin Köberle; Susanne Kaesler; Peter Thomas; Reinhard Mailhammer; Kamran Ghoreschi; Knut Schäkel; Boyko Amarov; Martin Eichner; Martin Schaller; Rachael A Clark; Martin Röcken; Tilo Biedermann
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

6.  Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: Interaction with chemokines and Th1 cytokine-producing cells.

Authors:  Guillaume Page; Guillaume Chevrel; Pierre Miossec
Journal:  Arthritis Rheum       Date:  2004-01

7.  Activated IL-22 pathway occurs in the muscle tissues of patients with polymyositis or dermatomyositis and is correlated with disease activity.

Authors:  Francesco Ciccia; Aroldo Rizzo; Riccardo Alessandro; Giuliana Guggino; Rosario Maugeri; Laura Saieva; Alessandra Cannizzaro; AnnaRita Giardina; Giacomo De Leo; Domenico Gerardo Iacopino; Giovanni Triolo
Journal:  Rheumatology (Oxford)       Date:  2014-03-05       Impact factor: 7.580

8.  Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis.

Authors:  Geun-Tae Kim; Mi-La Cho; Young-Eun Park; Wan Hee Yoo; Jung-Hee Kim; Hye-Jwa Oh; Dae-Sung Kim; Seung-Hoon Baek; Sun-Hee Lee; Jun-Hee Lee; Ho-Youn Kim; Sung-Il Kim
Journal:  Clin Rheumatol       Date:  2009-12-02       Impact factor: 2.980

9.  Interferon gamma suppresses collagen-induced arthritis by regulation of Th17 through the induction of indoleamine-2,3-deoxygenase.

Authors:  Jaeseon Lee; Jennifer Lee; Mi-Kyung Park; Mi-Ae Lim; Eun-Mi Park; Eun-Kyung Kim; Eun-Ji Yang; Seon-Yeong Lee; Joo-Yeon Jhun; Sung-Hwan Park; Ho-Youn Kim; Mi-La Cho
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

10.  Phenotypes of Peripheral Blood Lymphocytes and Cytokine Expression in Polymyositis and Dermatomyositis before Treatment and after Clinical Remission.

Authors:  Yasuhiro Shimojima; Wataru Ishii; Masayuki Matsuda; Shu-Ichi Ikeda
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2012-10-18
View more
  7 in total

1.  Apremilast in Recalcitrant Cutaneous Dermatomyositis: A Nonrandomized Controlled Trial.

Authors:  Carole Bitar; Thien Ninh; Katherine Brag; Soraya Foutouhi; Stella Radosta; Jade Meyers; Melody Baddoo; Delong Liu; Brittany Stumpf; Paul W Harms; Nakhle S Saba; Erin Boh
Journal:  JAMA Dermatol       Date:  2022-10-05       Impact factor: 11.816

2.  A high level of serum neopterin is associated with rapidly progressive interstitial lung disease and reduced survival in dermatomyositis.

Authors:  Q-L Peng; Y-M Zhang; L Liang; X Liu; L-F Ye; H-B Yang; L Zhang; X-M Shu; X Lu; G-C Wang
Journal:  Clin Exp Immunol       Date:  2019-12-18       Impact factor: 4.330

3.  Highly Multiplexed Mass Cytometry Identifies the Immunophenotype in the Skin of Dermatomyositis.

Authors:  Jay Patel; Spandana Maddukuri; Yubin Li; Christina Bax; Victoria P Werth
Journal:  J Invest Dermatol       Date:  2021-03-22       Impact factor: 7.590

4.  Serum levels of interleukins and S100A8/A9 correlate with clinical severity in patients with dermatomyositis-associated interstitial lung disease.

Authors:  Yueyan Lou; Yu Zheng; Bijun Fan; Liyan Zhang; Feng Zhu; Xiaodong Wang; Zhiwei Chen; Xiaoming Tan; Qing Wei
Journal:  BMC Pulm Med       Date:  2020-07-17       Impact factor: 3.317

5.  Apremilast as a potential treatment for moderate to severe dermatomyositis: A retrospective study of 3 patients.

Authors:  Carole Bitar; Jalal Maghfour; Hoang Ho-Pham; Brittany Stumpf; Erin Boh
Journal:  JAAD Case Rep       Date:  2019-01-30

6.  A novel model of dermatomyositis induced by membrane antigen and calciphylaxis in rats.

Authors:  Xin Zhao; Lingyu Li; Shasha Ge; Jinyu Liu; Shuang Li; Hongya Wang; Dayong Cai
Journal:  Biomed Rep       Date:  2022-02-24

7.  Hsp90 as a Myokine: Its Association with Systemic Inflammation after Exercise Interventions in Patients with Myositis and Healthy Subjects.

Authors:  Xiao Švec; Hana Štorkánová; Maja Špiritović; Kryštof Slabý; Sabína Oreská; Aneta Pekáčová; Barbora Heřmánková; Kristýna Bubová; Petr Česák; Haya Khouri; Gulalai Amjad; Heřman Mann; Martin Komarc; Karel Pavelka; Ladislav Šenolt; Josef Zámečník; Jiří Vencovský; Michal Tomčík
Journal:  Int J Mol Sci       Date:  2022-09-28       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.